<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in Australia is among the highest worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>We investigate whether similar treatment results for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> can be achieved in rural surgery as reported from metropolitan centres </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Retrospective analysis of prospectively collected follow-up data in a rural surgical centre in South Australia has been carried out </plain></SENT>
<SENT sid="3" pm="."><plain>Results of <z:hpo ids='HP_0000001'>all</z:hpo> patients undergoing surgical treatment for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are analysed, and <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stages and interventions over a 5-year period are included </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Five-year survival of <z:hpo ids='HP_0000001'>all</z:hpo> patients (n = 194) treated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> independent of stage and cause of <z:hpo ids='HP_0011420'>death</z:hpo> was 56%, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific 5-year survival was 64% </plain></SENT>
<SENT sid="5" pm="."><plain>Perioperative mortality was 1.7% </plain></SENT>
<SENT sid="6" pm="."><plain>Overall survival was 96% in stage 1, 92% in stage 2, 58% in stage 3 and 0% for patients with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> at the time of diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-specific survival ranged from 100% in stage 1 to 0% for patients with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Assessment of overall and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival of <z:hpo ids='HP_0000001'>all</z:hpo> patients undergoing surgery for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> over a 5-year time period in a rural South Australian centre shows that good long-term results can be achieved with low perioperative mortality </plain></SENT>
<SENT sid="9" pm="."><plain>These findings compare well with the results of other groups </plain></SENT>
</text></document>